Laurion Capital Management LP Decibel Therapeutics, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.83 - $5.03 $8,668 - $15,406
-3,063 Reduced 20.35%
11,990 $36,000
Q3 2021

Nov 15, 2021
SELL
$6.6 - $9.04 $34,663 - $47,478
-5,252 Reduced 25.87%
15,053 $116,000
Q2 2021

Aug 13, 2021
SELL
$6.39 - $11.51 $30,001 - $54,039
-4,695 Reduced 18.78%
20,305 $175,000
Q1 2021

May 14, 2021
BUY
$10.56 - $19.9 $264,000 - $497,499
25,000 New
25,000 $284,000

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email